FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tomoaki Morioka

Research Profile

Disorders

Chemicals & Drugs

Devices

Glucose Clamp Technique

Anatomy

Procedures

Concepts & Ideas

Regression Analysis

Co-author Network

Publications

TOP 3
Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Naoya Kawano; Eiko Lee; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Masaaki Inaba
Clinical impact of the leptin to soluble leptin receptor ratio on subclinical carotid atherosclerosis in patients with type 2 diabetes.
Shinya Fukumoto; Masaaki Inaba; Eiji Ishimura; Eiji Kimoto; Hidenori Koyama; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Shigeichi Shoji; Tetsuo Shoji; Ken Wakikawa; Masanori Emoto
Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
Tetsuo Shoji; Tatsuji Takahashi; Masanori Emoto; Shinya Fukumoto; Akihide Matsumoto; Katsuhito Mori; Tomoaki Morioka; Yoshiki Nishizawa; Masaaki Inaba
Thrice-weekly insulin injection with nurse's support for diabetic hemodialysis patients having difficulty with self injection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tomoaki Morioka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Naoya Kawano; Eiko Lee; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Masaaki Inaba
Clinical impact of the leptin to soluble leptin receptor ratio on subclinical carotid atherosclerosis in patients with type 2 diabetes.
Journal of atherosclerosis and thrombosis 2013;20(2):186-94.
2012: Shinya Fukumoto; Masaaki Inaba; Eiji Ishimura; Eiji Kimoto; Hidenori Koyama; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Shigeichi Shoji; Tetsuo Shoji; Ken Wakikawa; Masanori Emoto
Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
Diabetes research and clinical practice 2012;97(1):91-8.
2012: Tetsuo Shoji; Tatsuji Takahashi; Masanori Emoto; Shinya Fukumoto; Akihide Matsumoto; Katsuhito Mori; Tomoaki Morioka; Yoshiki Nishizawa; Masaaki Inaba
Thrice-weekly insulin injection with nurse's support for diabetic hemodialysis patients having difficulty with self injection.
Osaka city medical journal 2012;58(1):35-8.
2012: Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Tetsuo Shoji; Shinsuke Yamada; Masanori Emoto; Yasuo Imanishi; Eiko Lee; Masaaki Inaba
Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus.
Diabetology & metabolic syndrome 2012;4(1):53.
2012: Naoya Kawano; Hidenori Koyama; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Yasuhisa Okuno; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Masaaki Inaba
Association of endothelial and vascular smooth muscle dysfunction with cardiovascular risk factors, vascular complications, and subclinical carotid atherosclerosis in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2012;19(3):276-84.
2012: Yasuo Imanishi; Wataru Ando; Jun Hashimoto; Hiroshi Kaji; Keisuke Kobayashi; Yasato Komatsu; Hajime M Koyano; Takami Miki; Akimitsu Miyauchi; Katsuhito Mori; Tomoaki Morioka; Yuki Nagata; Koichi Oba; Takatoshi Saito; Takafumi Ueda; Masaaki Inaba
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
Journal of bone and mineral metabolism 2012;30(1):93-9.
2011: Yuki Nagata; Hiroshi Naka; Masanori Emoto; Yasuo Imanishi; Akira Ishii; Masafumi Kurajoh; Takami Miki; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Masaaki Inaba
Evaluation of bone markers in hypophosphatemic rickets/osteomalacia.
Endocrine 2011;40(2):315-7.
2011: Naoya Kawano; Katsuhito Mori; Masanori Emoto; Eiko Lee; Ikue Kobayashi; Yuko Yamazaki; Hiromi Urata; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Yoshiki Nishizawa; Masaaki Inaba
Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus.
Diabetes research and clinical practice 2011;91(3):316-20.
2010: Yohei Mima; Shinya Fukumoto; Hiroki Ueno; Hidenori Koyama; Shinji Tanaka; Tomoaki Morioka; Koka Motoyama; Masanori Emoto; Tetsuo Shoji; Yoshiki Nishizawa; Masaaki Inaba
Different effects of diabetic autonomic neuropathy on regional transcutaneous oxygen tension in patients with peripheral arterial disease.
Osaka city medical journal 2010;56(2):27-36.
2010: Hiroki Ueno; Hidenori Koyama; Takuhito Shoji; Masayo Monden; Shinya Fukumoto; Shinji Tanaka; Yoshiko Otsuka; Yohei Mima; Tomoaki Morioka; Katsuhito Mori; Atsushi Shioi; Hiroshi Yamamoto; Masaaki Inaba; Yoshiki Nishizawa
Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse.
Atherosclerosis 2010;211(2):431-6.
2010: Masanori Emoto; Katsuhito Mori; Eiko Lee; Naoya Kawano; Yuko Yamazaki; Shoko Tsuchikura; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2010;59(6):873-8.
2009: Eiko Lee; Masanori Emoto; Megumi Teramura; Shoko Tsuchikura; Hiroki Ueno; Kayo Shinohara; Tomoaki Morioka; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Yasuhisa Okuno; Masaaki Inaba; Yoshiki Nishizawa
The combination of IMT and stiffness parameter beta is highly associated with concurrent coronary artery disease in type 2 diabetes.
Journal of atherosclerosis and thrombosis 2009;16(1):33-9.
2006: Tetsuo Shoji; Hidenori Koyama; Tomoaki Morioka; Shinji Tanaka; Akane Kizu; Kohka Motoyama; Katsuhito Mori; Shinya Fukumoto; Atsushi Shioi; Noriko Shimogaito; Masayoshi Takeuchi; Yasuhiko Yamamoto; Hideto Yonekura; Hiroshi Yamamoto; Yoshiki Nishizawa
Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Diabetes 2006;55(8):2245-55.
2006: Takeshi Oomichi; Masanori Emoto; Tsutomu Tabata; Tomoaki Morioka; Yoshihiro Tsujimoto; Hideki Tahara; Tetsuo Shoji; Yoshiki Nishizawa
Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study.
Diabetes care 2006;29(7):1496-500.
2005: Takahiro Araki; Masanori Emoto; Hisayo Yokoyama; Koka Motoyama; Tomoaki Morioka; Hideki Tahara; Hidenori Koyama; Tetsuo Shoji; Yasuhisa Okuno; Masaaki Inaba; Yoshiki Nishizawa
Insulin resistance index as a predictor for pioglitazone treatment in type 2 diabetes.
Osaka city medical journal 2005;51(1):19-25.
2004: Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Short-term aerobic exercise improves arterial stiffness in type 2 diabetes.
Diabetes research and clinical practice 2004;65(2):85-93.
2004: Hisayo Yokoyama; Masanori Emoto; Takahiro Araki; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Yasuhisa Okuno; Yoshiki Nishizawa
Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes.
Diabetes care 2004;27(7):1756-8.
2004: Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Miyoko Komatsu; Hideki Tahara; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose.
The Journal of clinical endocrinology and metabolism 2004;89(3):1481-4.
2003: Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Miyoko Komatsu; Hideki Tahara; Tetsuo Shoji; Yasuhisa Okuno; Yoshiki Nishizawa
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients.
Diabetes care 2003;26(8):2426-32.
2003: Hideki Ueda; Eiji Ishimura; Tetsuo Shoji; Masanori Emoto; Tomoaki Morioka; Naoki Matsumoto; Shinya Fukumoto; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
Factors affecting progression of renal failure in patients with type 2 diabetes.
Diabetes care 2003;26(5):1530-4.
2003: Tomoaki Morioka; Hidenori Koyama; Hisako Yamamura; Shinji Tanaka; Shinya Fukumoto; Masanori Emoto; Hiroyuki Mizuguchi; Takao Hayakawa; Itaru Kojima; Katsuhito Takahashi; Yoshiki Nishizawa
Role of H1-calponin in pancreatic AR42J cell differentiation into insulin-producing cells.
Diabetes 2003;52(3):760-6.
2003: Shigehiko Fujiwara; Masanori Emoto; Miyoko Komatsu; Koka Motoyama; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Arterial wall thickness is associated with insulin resistance in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2003;10(4):246-52.
2001: Tomoaki Morioka; Masanori Emoto; Tsutomu Tabata; Tetsuo Shoji; Hideki Tahara; H Kishimoto; Eiji Ishimura; Yoshiki Nishizawa
Glycemic control is a predictor of survival for diabetic patients on hemodialysis.
Diabetes care 2001;24(5):909-13.